October 2016

Mon, 31/10/2016 - 09:00
ReViral, an antiviral drug discovery and development company developing innovative therapies against Respiratory Syncytial Virus (RSV), announced today the initiation of a Phase 1 clinical trial for RV521, its novel orally-active small molecule inhibitor of RSV fusion.
Wed, 26/10/2016 - 17:15
Salt Lake City, USA, 14th October 2016 / Sciad Newswire / The Institute for Healthcare Valuation (IHV) and Consul
Tue, 25/10/2016 - 16:48
London, UK, 25th October 2016 / Sciad Newswire / The RSA Group, the world's largest Talent Consultancy in Life Sciences, has announced the appointment of Natalie
Mon, 24/10/2016 - 09:00
NALIA Systems, a developer of novel multiplex immunodiagnostic systems for clinical and research applications, announces the expansion of its board following the recent successful £500,000 fund raising.
Tue, 18/10/2016 - 14:45
London, UK, 18th October 2016 / Sciad Newswire / NALIA Systems, a developer of novel multiplex immunodiagnostic systems for clinical and research applications, ha
Tue, 18/10/2016 - 10:30
The RSA Group - the world’s largest talent consultancy in life sciences - announces the appointment of Thomas Schleimer as a Partner. 
Tue, 18/10/2016 - 09:30
An international group of population health experts is calling for sharing of health data to be the norm if precision health agendas are to succeed and build sustainable health systems.
Mon, 17/10/2016 - 01:00
Professor Clifford Hughes was speaking in anticipation of the publication of a White Paper published by the International Journal for Quality in Health Care (ISQua) today which discusses the impact of current and impending pressure of ageing populations which will present significant planning and budgetary challenges for global healthcare systems.
Tue, 11/10/2016 - 08:00
According to new research from specialist recruiter Hobson Prior, home-working is growing ever more popular in the life sciences sector: 32% of professionals surveyed have seen an increase in the number of home-working opportunities available.
Mon, 10/10/2016 - 15:07
Manchester, UK, 29th September 2016 / Sciad Newswire / Pharmaceutical firm Mundipharma and Premier League club Manches

Pages